North America

Remiges Ventures to raise $150 mln venture-capital fund

Remiges Ventures has set out to raise a $150 million second venture-capital fund, according to a filing with the SEC.

Arrhythmia care company Acutus Medical gathers $170 mln

Carslbad, California-based Acutus Medical, an arrhythmia care company, has secured $100 million in Series D funding and a $70 million credit facility. The Series D investors included 8VC, Opaleye Management, Pura Vida Investments, OrbiMed, Deerfield Management Company, Advent Venture Partners, Xeraya Capital and GE Ventures. OrbiMed Credit and Royalties Fund and Deerfield Management provided the credit facility.

BlockCerts raises $25 mln in financing from Hillcore, Robson

BlockCerts Blockchain, a Victoria, British Columbia-based blockchain smart contracts and transactions platform, has raised $25 million in financing. The money came from Canadian private investment firms Hillcore Group and Robson Financial Group. BlockCerts was founded in 2016 by Tim Vasko, who is also CEO of the company's parent organization Finaeos. It provides a smart contracts streaming solution, a suite of software-as-a-service solutions, and distributed ledger technology to help businesses access blockchain and secure transactions. The funds raised will support global expansion and adoption of BlockCerts' platform.

Jumpspeed Ventures wraps up new fund

Jumpspeed Ventures, an Israeli venture firm, has closed its new fund at $17.7 million, according to an announcement on the site. Jumpspeed invests in early-stage startups based in Jerusalem.

Casdin Capital backs Codexis

Redwood City, California-based Codexis, a synthetic biology company, has secured $50 million in funding. The investor was Casdin Capital LLC.

Xealth rallies $3 mln

Xealth, a platform for connecting digital health, has secured $3 million in funding. The investors included Atrium Health, Cleveland Clinic, MemorialCare Innovation Fund, McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures, Providence Ventures, UPMC, Froedtert and the Medical College of Wisconsin health network.

CoHive attracts $13.5 mln

CoHive, a newly launched Indonesian co-working space company, has secured $13.5 million in financing. Stonebridge Ventures led the round.

Digital workplace platform Unily pulls in $68 mln

Unily, a digital workplace platform, has secured $68 million in funding, according to an announcement on its site. The backers were Silversmith Capital Partners and Farview Equity Partners.

VC-backed Akero Therapeutics debuts IPO

Akero Therapeutics Inc, a biotech firm, has raised about $92 million for its IPO after pricing its 5.75 million shares at $16 per share. The stock began trading June 20, 2019 on the NASDAQ under the ticker symbol "AKRO." J.P. Morgan Securities LLC, Jefferies LLC and Evercore Group L.L.C. are the lead underwriters. Akero's pre-IPO investors included Janus Henderson Investors, Redmile Group, Boxer Capital of Tavistock Group, Cormorant Asset Management, BVF Partners, Rock Springs Capital, LifeSci Venture Partners, Apple Tree Partners, Atlas Venture, venBio Partners and Versant Ventures.

Prevail Therapeutics begins trading on NASDAQ

New York City-based Prevail Therapeutics, a gene therapy company, has gone public after pricing its over 7.3 million shares at $17 per share. The stock began trading June 20, 2019 on the NASDAQ under the ticker symbol "PRVL." Morgan Stanley, BofA Merrill Lynch and Cowen are the lead underwriters. Prevail’s pre-IPO backers included OrbiMed, Pontifax Fund, RA Capital Management, EcoR1 Capital, Omega Funds, BVF Partners LP, Boxer Capital LLC, Adage Capital Management LP and Alexandria Venture Investments.